Understanding

LIGHT THERAPY

Transcranial photobiomodulation is known as brain light therapy. Light therapy involves the use of light-emitting diodes (LEDs) to deliver a specific wavelength of light that can be absorbed by cells in the body.

What is Photobiomodulation?

Photobiomodulation is otherwise known as light therapy.

Light therapy involves the use of light-emitting diodes (LEDs) to deliver a specific wavelength of light that can be absorbed by cells in the body. The LED type determines the wavelength of light and can be tuned to a particular tissue or organ.

Information contained on this website is intended for educational and informational purposes only and does not constitute medical advice, diagnosis, or a substitute for advice from a licensed healthcare practitioner.

All biological activity in our body requires ATP just like plants require chlorophyl.

Transcranial photobiomodulation is painless, non-invasive, systemic, drug-free and has shown to have no negative side effects when used appropriately.

Proven Effects of PBM

Reduce Inflammation

Increases Circulation

Increases Cellular Energy

    History of Light Therapy

    Light therapy has been used for centuries for healing purposes. Hippocrates discovered that applying sunlight to the skin could relieve ailments such as rickets, scurvy and arthritis. However, until recently, scientists began understanding how this worked on a cellular level.

    bnm-01
    gvb-01
    nvn-01
    redr-01
    zdfx-01

    Understanding Wavelengths:
    810 vs 1070

    The 1070nm LED’s are unique in that they penetrate further into the skull targeting the mitochondria. A study named Photobiomodulation at Different Wavelengths (Pruit, 2022) shows the difference between two wavelengths around 800 and 1070. The study states “the 1064nm sustained longer and more increases of the physiological effects as compared to the other.” The study was done with lasers first, then compared to LED’s, and suggested using LED’s as a safer and more important role in the development of PBM.

    Research is also being conducted in the UK by Paul Chazot at Durham University and he explains clearly in this video why the 1070 is the wavelength they are focused on.

    Information contained on this website is intended for educational and informational purposes only and does not constitute medical advice, diagnosis, or a substitute for advice from a licensed healthcare practitioner.

    A Cellular Breakdown

    Photobiomodulation is defined as the use of light energy to trigger photochemical changes within cellular structures (mitochondria) that are receptive to red and near-infrared (NIR) light. The mitochondria produce cellular energy by producing a molecule called adenosine triphosphate (ATP). The energy from ATP enables us to carry out all physiological activities and provides energy to the brain cells. In addition, application of light energy leads to greater blood flow to the brain – allowing delivery of nutrients and removal of waste products.

    This is a new way of ‘charging’ the brain and now research is starting to show significant benefit of this therapy for brain health

    Using EEG to Apply PBM

    The Neuronic device, known as Neuradiant 1070, operates with four quadrants meticulously programmed to toggle between on and off states or different pulse rates, all synchronized with the data derived from the user’s qEEG scan. This innovative approach enables us to harness the power of photobiomodulation in tandem with qEEG data, facilitating the delivery of specific protocols and brain entrainment experiences. As a result, we exclusively offer consultation services in conjunction with the 4-quadrant device to maximize its potential.
    Learn more about consultation
    Information contained on this website is intended for educational and informational purposes only and does not constitute medical advice, diagnosis, or a substitute for advice from a licensed healthcare practitioner.

    “Photobiomodulation is more than an alternative kind of medical treatment. It is a whole new method to control cellular processes and modulate living organisms by precise alterations in the chemistry of biomolecules."

    Harvard Pioneer Researcher, Michael Hamblin, PhD

    Key Mechanism in Action

    The expression of several genes and proteins that play a role in disease mechanisms seen in cognitive decline surprisingly changes during long-term use of Photobiomodulation (PBM) (Bathini, Raghushaker and Mahato, 2020).

    By now, we can understand that mitochondrial dysfunction appears to be a central mediator of neurodegenerative disease pathogenesis and disease progression.

    Glossary

    APOPTOSIS

    noun[ a-puhp-tow-suhs ]

    is the process of programmed cell death. It is used during early development to eliminate unwanted cells, for example, those between the fingers of a developing hand. In adults, apoptosis is used to rid the body of cells that have been damaged beyond repair.

    Proliferation

    noun[ pruh-li-fr-ay-shn ]

    rapid reproduction of a cell, part, or organism.

    Oxidative stress

    noun[ aak-suh-day-tuhv ]
    is a phenomenon caused by an imbalance between production and accumulation of oxygen reactive species (ROS) in cells and tissues and the ability of a biological system to detoxify these reactive products

    ATP

    noun[ ei-ti-pi ]
    (Adenosine triphosphate) is an organic compound that provides energy to drive many processes in living cells, such as muscle contraction, nerve impulse propagation, condensate dissolution, and chemical synthesis.

    Neurofeedback

    noun[ nur-ow-feed-bak ]
    also called neurotherapy, is a type of biofeedback that presents real-time feedback from brain activity in order to reinforce healthy brain function through operant conditioning.

    Blogs

    Keep up to date on news and events, follow us for updates, subscribe to our channels and stay informed.
    See All Our Blog Posts

    References

    • Hamblin, M., 2016. Photobiomodulation or low-level laser therapy. Journal of Biophotonics, 9(11-12), pp.1122-1124.
    • Bathini, M., Raghushaker, C. and Mahato, K., 2020. The Molecular Mechanisms of Action of Photobiomodulation Against Neurodegenerative Diseases: A Systematic Review. Cellular and Molecular Neurobiology, 42(4), pp.955-971.
    • Tyrell Pruitt, Caroline Carter, Xinlong Wang, Anqi Wu, Hanli Liu. 2022. Photobiomodulation at Different Wavelengths Boosts Mitochondrial Redox Metabolism and Hemoglobin Oxygenation: Lasers vs. Light-Emitting Diodes In Vivo
    • Amir Oron, Uri Oron, Jackson Streeter, Luis De Taboada, Alexander Alexandrovich, Victoria trembovler, and Esther Shohami. Low-Level Laser Therapy Applied Transcranially to Mice following Traumatic Brain Injury Significantly Reduces Long-Term Neurological Deficits, 2007.